Institutional & Family Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.13K | Hold |
21
| – | – | ﹤0.01% | 621 |
|
|
2024
Q1 | $1.43K | Hold |
21
| – | – | ﹤0.01% | 605 |
|
|
2023
Q4 | $1.32K | Hold |
21
| – | – | ﹤0.01% | 588 |
|
|
2023
Q3 | $953 | Hold |
21
| – | – | ﹤0.01% | 620 |
|
|
2023
Q2 | $1.18K | Hold |
21
| – | – | ﹤0.01% | 611 |
|
|
2023
Q1 | $950 | Hold |
21
| – | – | ﹤0.01% | 632 |
|
|
2022
Q4 | $854 | Hold |
21
| – | – | ﹤0.01% | 612 |
|
|
2022
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 617 |
|
|
2022
Q2 | $1K | Hold |
21
| – | – | ﹤0.01% | 636 |
|
|
2022
Q1 | $1K | Sell |
21
-23
| -52% | -$1.1K | ﹤0.01% | 680 |
|
|
2021
Q4 | $3K | Buy |
44
+7
| +19% | +$477 | ﹤0.01% | 616 |
|
|
2021
Q3 | $4K | Buy |
37
+4
| +12% | +$432 | ﹤0.01% | 693 |
|
|
2021
Q2 | $5K | Buy |
33
+2
| +6% | +$303 | ﹤0.01% | 700 |
|
|
2021
Q1 | $4K | Buy |
+31
| New | +$4K | ﹤0.01% | 710 |
|